Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
C

Centrum Medyczne Enel Med SA
WSE:ENE

Watchlist Manager
Centrum Medyczne Enel Med SA
WSE:ENE
Watchlist
Price: 23 PLN 0.88% Market Closed
Market Cap: zł650.4m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
+36%
5Y
+46%
10Y
+224%
Liabilities
+
3Y
+41%
5Y
+34%
10Y
+458%
Equity
+
3Y
+25%
5Y
+82%
10Y
+68%

Balance Sheet Decomposition
Centrum Medyczne Enel Med SA

Balance Sheet
Centrum Medyczne Enel Med SA

Rotate your device to view
Balance Sheet
Currency: PLN
Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
3
1
0
2
5
0
1
52
21
6
8
6
8
18
75
23
Cash
0
0
0
1
4
0
0
52
16
4
5
4
6
16
0
0
Cash Equivalents
3
1
0
0
0
0
0
0
5
3
2
2
2
2
75
23
Short-Term Investments
0
0
0
0
0
0
0
0
0
8
6
1
1
1
3
3
Total Receivables
7
10
8
11
11
11
16
12
15
21
26
34
24
20
21
25
Accounts Receivables
7
10
8
11
10
11
15
11
12
18
23
32
22
18
20
25
Other Receivables
1
0
0
0
0
0
1
1
3
4
3
3
2
2
1
0
Inventory
1
1
1
1
1
1
1
1
2
2
2
4
4
5
3
4
Other Current Assets
1
2
1
2
4
2
2
1
12
2
3
3
2
3
3
4
Total Current Assets
11
13
10
16
20
15
19
71
50
40
45
48
40
46
105
60
PP&E Net
30
48
54
52
92
95
109
94
126
146
150
154
359
333
311
341
PP&E Gross
30
48
54
52
92
95
109
94
126
146
150
154
359
333
311
341
Accumulated Depreciation
4
10
18
26
36
49
10
16
31
46
66
87
138
190
243
288
Intangible Assets
0
2
2
2
2
2
3
3
4
4
5
6
7
7
14
17
Goodwill
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
3
Note Receivable
0
1
2
2
1
1
1
1
0
0
0
0
0
0
0
0
Long-Term Investments
1
1
1
2
5
5
5
1
4
2
4
4
5
5
6
6
Other Long-Term Assets
1
1
1
1
1
2
0
0
4
4
4
4
3
0
1
5
Other Assets
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
3
Total Assets
43
N/A
65
+52%
69
+6%
74
+8%
119
+61%
119
0%
137
+15%
170
+24%
188
+10%
196
+5%
208
+6%
217
+4%
414
+91%
393
-5%
438
+11%
432
-1%
Liabilities
Accounts Payable
12
17
16
15
21
16
18
18
26
28
28
38
28
28
32
37
Accrued Liabilities
3
6
7
7
5
5
1
6
6
8
12
10
11
11
12
15
Short-Term Debt
0
0
0
0
0
10
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
2
7
6
12
11
7
13
16
19
20
22
25
54
46
45
49
Other Current Liabilities
1
5
6
0
0
2
7
2
2
2
3
2
1
2
4
4
Total Current Liabilities
18
35
34
35
37
41
38
43
53
58
65
74
94
87
94
104
Long-Term Debt
9
13
9
19
22
24
20
10
10
13
22
20
205
199
160
169
Deferred Income Tax
0
0
1
1
1
2
5
5
6
6
6
5
5
1
1
0
Minority Interest
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
Other Liabilities
1
3
8
2
7
9
6
3
12
11
10
13
7
7
7
6
Total Liabilities
29
N/A
51
+74%
52
+3%
56
+8%
66
+17%
75
+14%
69
-8%
61
-12%
80
+33%
87
+9%
102
+17%
113
+10%
312
+177%
294
-6%
262
-11%
280
+7%
Equity
Common Stock
12
14
14
17
24
24
24
24
24
24
24
24
24
24
28
28
Retained Earnings
2
0
0
1
30
21
39
79
39
16
6
5
3
1
48
25
Additional Paid In Capital
0
0
0
0
0
0
0
0
0
25
25
25
25
25
99
99
Other Equity
0
0
2
0
0
0
6
6
45
45
51
51
51
51
0
0
Total Equity
14
N/A
14
+6%
17
+17%
18
+5%
54
+205%
44
-18%
68
+53%
109
+61%
107
-2%
109
+1%
106
-3%
105
-1%
102
-2%
99
-3%
176
+78%
152
-13%
Total Liabilities & Equity
43
N/A
65
+52%
69
+6%
74
+8%
119
+61%
119
0%
137
+15%
170
+24%
188
+10%
196
+5%
208
+6%
217
+4%
414
+91%
393
-5%
438
+11%
432
-1%
Shares Outstanding
Common Shares Outstanding
24
24
24
24
24
24
24
24
24
24
24
24
24
24
28
28

See Also

Summary
ENE intrinsic value, competitors valuation, and company profile.
DCF Valuation
ENE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ENE stock valuation using valuation multiples.
Wall Street Estimates
ENE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ENE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 318,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.